More articles from Volume 50, Issue 1, 2021
A new scoring system for Covid-19 in patients on hemodialysis: Modified Early Warning score
Analysis of the occurrence, location and treatment of laryngeal carcinoma recurrence
Orthodontic treatment of a disto-occlusion with and favorable growth pattern
Sensory processing disorders in premature infants
Examination of early adaptation of newborns small for gestational age
Secondary hyperaldosteronism and hypertension
,
Miloš Mijalković
,
Slavica Pajović
,
Aleksandar Jovanović
Maja Šipić
Abstract
References
1.
Sudano I, Beuschlein F, Lüscher TF. Secondary causes of hypertension. ESC CardioMed. 2018. p. 2409–19.
2.
Charles L, Triscott J, Dobbs B. Secondary Hypertension: Discovering the Underlying Cause. Vol. 96. 2017. p. 453–61.
3.
Dominguez A, V M, StatPearls GSH. 2020.
4.
Shen H, Xu Z, Li Q. New advances in the diagnosis of primary aldosteronism. Vol. 6, Chronic Diseases and Translational Medicine. 2020. p. 1–5.
5.
Rossi GP. Primary Aldosteronism. Secondary Hypertension. 2020. p. 59–78.
6.
Papadopoulou-Marketou N, Vaidya A, Dluhy R. Hyperaldosteronism.
7.
Wang W, Wei F, Li R, Tian J. A case report of idiopathic hyperaldosteronism characterized by bilateral adrenal adenoma. Vol. 98, Medicine. p. e17418.
8.
Zhao L, Liu W, Yu X, Li H. A 100-year old patient presented with profound diuretic-induced hypokalemia as first indicator of primary aldosteronism: a case report. Vol. 9. 2016. p. 12361–4.
9.
Nakamaru R, Yamamoto K, Nozato S, Hongyo K, Nagasawa M, Hagiya H, et al. A case of primary aldosteronism with resistant hypertension successfully treated by unilateral adrenalectomy after unsuccessful classification of subtype in adrenal venous sampling. Vol. 7, Clinical Case Reports. 2019. p. 1895–9.
10.
Francis GS, Tang WHW. Should we consider aldosterone as the primary screening target for preventing cardiovascular events?**Editorials published in the Journal of American College of Cardiologyreflect the views of the authors and do not necessarily represent the views of JACCor the American College of Cardiology. Vol. 45, Journal of the American College of Cardiology. 2005. p. 1249–50.
11.
Catena C. Cardiovascular Outcomes in Patients With Primary Aldosteronism After Treatment. Vol. 168, Archives of Internal Medicine. 2008. p. 80.
12.
Fathimah M, Gunavathy M, Nadzimah. A Case of Resistant Hypertension Secondary to Primary Aldosteronism. Vol. 4. 2014. p. 61–4.
13.
Zoran A. Primary hyperaldosteronism: diagnostic proseduere and treatment. Vol. 6. 2003. p. 37–48.
14.
Vakkalanka S, Zhao A, Samannodi M. Primary hyperaldosteronism: a case of unilateral adrenal hyperplasia with contralateral incidentaloma. BMJ Case Reports. p. bcr2016216209.
15.
Lechner B, Lechner K, Heinrich D, Adolf C, Holler F, Schneider H, et al. THERAPY OF ENDOCRINE DISEASE: Medical treatment of primary aldosteronism. Vol. 181, European Journal of Endocrinology. 2019. p. R147–53.
16.
Novakovic T, S. P, Endocrinology KM. 2010.
17.
Goh BKP, Tan Y, Chang KTE, Eng PHK, Yip SKH, Cheng CWS. Primary Hyperaldosteronism Secondary to Unilateral Adrenal Hyperplasia: an Unusual Cause of Surgically Correctable Hypertension. A review of 30 cases. Vol. 31, World Journal of Surgery. 2007. p. 72–9.
Citation
Copyright
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Article metrics
Google scholar:
See link
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
